date,title,source
Oct-17-18,"Investor Expectations to Drive Momentum within Matthews International, AC Immune SA, Entercom Communications, Sunrun, Axcelis Technologies, and Advanced Disposal Services  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-22-18,"AC Immune Announces Dr. Andreas Muhs, Chief Scientific Officer, to Take Medical Leave of Absence",GlobeNewswire
Oct-25-18,AC Immune Selected to Present Progress on its Tau Morphomer Program in the Late Breaking News Session at CTAD Conference in Barcelona,GlobeNewswire
Oct-29-18,AC Immune Partner Life Molecular Imaging Presents New Clinical Study Results for Tau PET-Tracer 18F-PI-2620,GlobeNewswire
Oct-29-18,AC Immune SA: New Data Supporting Crenezumab as Potential Alzheimer's Therapy,GlobeNewswire
Nov-01-18,AC Immune to Present at 2018 Society for Neurosciences Meeting,GlobeNewswire
Nov-01-18,AC Immune to Host Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer's Disease (AD) and the Involvement of Other Misfolded Proteins in AD and Neurodegenerative Diseases,GlobeNewswire
Nov-05-18,Earnings Preview: AC Immune (ACIU) Q3 Earnings Expected to Decline,Zacks
